Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 30 Jun 2026Bulevirtide: the first FDA-approved treatment for chronic hepatitis DTopic:Hepatitis D
  • 12 Jun 2026FDA approves first and only oral option for COVID-19 postexposure prophylaxisTopic:Coronavirus disease 2019 (COVID-19)
  • 09 Jun 2026WHO advises on candidate vaccines and therapeutics for Ebola outbreakTopic:Ebola disease
  • 29 May 2026Hantavirus outbreak linked to cruise shipTopic:Hantavirus cardiopulmonary syndrome
  • 22 May 2026FDA expands approval of teplizumab to include children aged ≥1 yearTopic:Type 1 diabetes mellitus
  • 15 May 2026US cervical cancer screening guidelines include the option of self-collection of vaginal samplesTopic:Cervical cancer
  • 14 May 2026Tazemetostat withdrawn globally for all indications (including follicular lymphoma) due to risk of secondary hematologic malignanciesTopic:Non-Hodgkin lymphoma
  • 06 May 2026FDA approves new oral antibiotics effective against resistant strains of gonorrheaTopic:Urethritis
  • 18 Mar 2026Food and Drug Administration (FDA) approves labeling changes to menopausal hormone therapiesTopic:Menopause
  • 06 Mar 2026New BMJ Best Practice topic on postpartum psychosis now liveTopic:Postpartum psychosis
  • 25 Feb 2026FDA approves nerandomilast for treatment of idiopathic pulmonary fibrosis in adultsTopic:Idiopathic pulmonary fibrosis
  • 30 Jan 2026Antiparasitic monotherapy recommended as treatment option for select cases of cystic echinococcosisTopic:Tapeworm infection
  • 28 Jan 2026European guidance lowers the bar for starting antiviral therapy in chronic HBVTopic:Hepatitis B
  • 13 Nov 2024US FDA approves new treatment for schizophrenia, the first drug with a novel target in decadesTopic:Schizophrenia
  • 06 Aug 2024Updated American College of Gastroenterology guidance includes new fluid resuscitation recommendations for patients with acute pancreatitisTopic:Acute pancreatitis